For women, the most effective biohacks are actually the foundational ones that many of these extreme protocols overlook
Foundayo is not yet approved in the UK
The core finding was that participants taking tirzepatide were significantly less likely to see their depressive symptoms worsen and more likely to see them improve compared to those taking a placebo
Constipation, while less common than diarrhea, may also occur and can be particularly problematic in patients with pre-existing constipation issues
Retatrutide is a triple agonist for GLP-1, GIP, and glucagon receptors, which produces its superior weight loss results compared to single or dual agonists
Safety and Effectiveness of GLP-2 and GLP-3 Safety is paramount, and GLP-2 and GLP-3 is generally well-tolerated